BiotaX

Decoding Precision Medicine
 
Discovering new targets for Diagnostics and Therapeutics through Systems Biology and Artificial Intelligence

Our Technology

BiotaX has developed deep explainable AI models based on system biology that can collect, analyze and predict multiple disease states and calculate optimal interventions supported by cutting-edge meta-genomic AI analysis.

TaxonAI- Novel deep insights Computetional Platform 

BiotaX's deep explainable AI models based on system biology can predict multiple disease states and calculate optimal interventions supported by cutting-edge meta-genomic AI analysis platforms.

BewitchedAntiqueAllensbigearedbat-size_restricted.gif
iStock-1163670497.jpg

CustomeBiome

BiotaX is the only technology platform capable of comprehensive multi-omics solution based on microbiome and system biology.  Our patented CustomBiome presents next-generation LBP production technology, which is able to isolate targeted live microbes on the strain level ( TaxonAI Output ) based either on their taxonomy or gene functional BiotaX can package these microbes as customized live biotherapeutic products (LBPs) to fight dysbiosis in a personalized and disease-specific way.

Featured Projects

Leadership Team

NAAMA.jpg
IMG_20170917_183316_edited_edited.jpg
IMG_20200511_140254_edited.jpg

Prof. Naama Geva-Zatorsky

Co-Founder, CS

Head of the Microbiome Lab,The Technion, Rappaport Faculty of Medicine,  Technion Integrated Cancer Center.Her research combining systems-biology with microbiology and immunology to study the interactions between gut microbes and the host immune system in health and disease. Her Ph.D from the Weizmann Institute, studying systems-biology of protein dynamics in cancer. Her postdoctoral was at Harvard Medical School, studying gut microbiota-host interactions

Shay Hilel

Co Founder, CEO

Serial entrepreneur with vast experience as founder, senior executive & business manager CEO and Co founder of BrainVu (Acquired in 2018 ). Head of the Alcatel Lucent Digital Multimedia Division (Was Spin-off and acquired by Nantworks in 2014 ). Shay worked both in startups and corporate organizations with a verity of hands-on technology leadership roles

Dean Light

Co Founder,CTO

A computational biology & SW architect expert focusing on complex multidisciplinary problems. Prior to BiotaX, Dean was software architect @Technion Data & Knowledge (TDK) Lab - the computer science faculty and developer team lead @Lamm lab - the department of biology , Technion.
Dean holds an M.Sc. in Biology and B.Sc. in both Mathematics and Computer Science from the Technion.
Dean is a recipient of the 2019 Sherman award for distinguished academic achievement in multidisciplinary research.

Advisory Board / Consulting

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle Feb 8 2021

Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle of Illumina Accelerator Cambridge, UK and five companies for the twelfth funding cycle of Illumina Accelerator San Francisco Bay Area. The newest companies to join Illumina Accelerator’s portfolio of genomics startups include: BiotaX Labs LTD, a spinoff from Technion Research and Development Foundation (TRDF) Israel, is harnessing the power of the microbiome to diagnose and provide effective, tailored and safe microbial treatments.